Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0090
0.00 (0.00%)
Feb 11, 2026, 1:12 PM EST
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $4.95M in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $17.73M, up 3.67% year-over-year. In the year 2024, Evofem Biosciences had annual revenue of $19.36M with 6.28% growth.
Revenue (ttm)
17.73M
Revenue Growth
+3.67%
P/S Ratio
0.07
Revenue / Employee
553.94K
Employees
32
Market Cap
1.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.36M | 1.15M | 6.28% |
| Dec 31, 2023 | 18.22M | 1.38M | 8.20% |
| Dec 31, 2022 | 16.84M | 8.59M | 104.23% |
| Dec 31, 2021 | 8.24M | 7.80M | 1,748.43% |
| Dec 31, 2020 | 446.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| International Stem Cell | 9.39M |
| Lipella Pharmaceuticals | 389.78K |
| Halberd | 6.94K |
Evofem Biosciences News
- 20 days ago - Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026 - Business Wire
- 22 days ago - Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store - Business Wire
- 2 months ago - Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PRNewsWire
- 3 months ago - Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PRNewsWire
- 4 months ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire
- 4 months ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire
- 4 months ago - Evofem Biosciences Honors World Contraception Day - PRNewsWire
- 5 months ago - Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PRNewsWire